Kirwan Surgical Products LLC Disposable 25-gauge bipolar pencil, straight, Long. Model/Catalog Nu...
FDA Device Recall #Z-0655-2025 — Class I — November 14, 2024
Recall Summary
| Recall Number | Z-0655-2025 |
| Classification | Class I — Serious risk |
| Date Initiated | November 14, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Kirwan Surgical Products, LLC |
| Location | Marshfield, MA |
| Product Type | Devices |
| Quantity | 66 units |
Product Description
Kirwan Surgical Products LLC Disposable 25-gauge bipolar pencil, straight, Long. Model/Catalog Number: 14-5011L The Disposable Microsurgical Bipolar Pencil are designed for use in eye surgery, and other soft tissue procedures. For instance, the pencils are designed for cauterization of the retinal area during surgical procedures. The current line of pencils all have the same molded handle. The pencils' tip outer diameter is 25 gauge.
Reason for Recall
Potential for the outer stainless-steel tube to break or detach.
Distribution Pattern
Worldwide - US Nationwide including PUERTO RICO; AUSTRALIA, CANADA, CHILE, COLOMBIA, DENMARK, EGYPT, ENGLAND, FRANCE, GERMANY, ISRAEL, ITALY, JAPAN, MEXICO, NETHERLANDS, PHILIPPINES, SOUTH AFRICA, SWITZERLAND, TAIWAN, THAILAND, TRINIDAD, TURKEY, UNITED ARAB EMIRATES, and VENEZUELA.
Lot / Code Information
Model/Catalog Number: 14-5011L. GTINs: Pouch - 00841019101056, Inner Pack - 10841019101053, Case - 20841019101050. Sterile Lot Number: 221020. All expiration dates from 2027-09-01(YYYY-MM_DD) on would encompass the for the recall.
Other Recalls from Kirwan Surgical Products, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0660-2025 | Class I | Optikon Bipolar Pencil 25 Gauge Straight. Model... | Nov 14, 2024 |
| Z-0658-2025 | Class I | Walcott Bipolar Pencil 25 Gauge Straight. Model... | Nov 14, 2024 |
| Z-0657-2025 | Class I | Ambler Surgical Bipolar Pencil 25 Gauge Straigh... | Nov 14, 2024 |
| Z-0659-2025 | Class I | Nidek Co. Disposable Bipolar Pencil 25 Gauge St... | Nov 14, 2024 |
| Z-0656-2025 | Class I | Accutome/Microsurgical Disposable Bipolar Penci... | Nov 14, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.